Article Text

Download PDFPDF
Modulation of cortical excitability to normalise brain function and improve cognition in multiple sclerosis

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


  • Contributors MAR was invited to write the editorial commentary and drafted the manuscript. MF was involved in the discussion and in the manuscript editing.

  • Competing interests MAR received speakers’ honoraria from Biogen Idec, Novartis, Genzyme, Sanofi-Aventis, Teva Pharmaceutical Industries and Excemed and receives research support from the Italian Ministry of Health and Fondazione Italiana Sclerosi Multipla. MF is Editor-in-Chief of the Journal of Neurology; serves on scientific advisory board for Teva Pharmaceutical Industries; has received compensation for consulting services and/or speaking activities from Biogen Idec, Excemed, Novartis, and Teva Pharmaceutical Industries; and receives research support from Biogen Idec, Teva Pharmaceutical Industries, Novartis, Italian Ministry of Health, Fondazione Italiana Sclerosi Multipla, Cure PSP, Alzheimer's Drug Discovery Foundation (ADDF), the Jacques and Gloria Gossweiler Foundation (Switzerland), and ARiSLA (Fondazione Italiana di Ricerca per la SLA).

  • Provenance and peer review Commissioned; internally peer reviewed.

Linked Articles